V3 Healthcare Strategies Launches ELEO Patented Single Use Safety Tourniquet to the North American Marketplace

MILWAUKEE, Oct. 27, 2014 /PRNewswire/ -- V3 Healthcare Strategies, a Wisconsin Based Accountable Care Strategies company, announced the timely North American launch of the revolutionary ELEO Single Use Tourniquet. The "Easy Lock Easy Opening" Cross Infection Prevention Product comes to market amidst an environment of infectious, catastrophic diseases such as Ebola, Hanta & Hemorrhagic Fevers, while simultaneously protecting against all other infectious diseases such as HIV/AIDS, Hepatitis and more. According to Dr. Paul A. Markham, President, "This North American launch of ELEO™ brings forth a revolutionary, timely and clinician safety centered approach, to the often hidden threat of tourniquet cross infection reduction and safety. ELEO™ enters the North American market following wide scale acceptance in the United Kingdom. With a deep heritage in providing solutions for Mad Cow disease in the UK, ELEO designers constantly deliver unique solutions to improve safety, clinician productivity in lockstep with current Care Coordination Requirements. All V3 products such as ELEO™, reinforce a sincere commitment to improving clinician safety, patient outcomes, while avoiding unnecessary costs, in conjunction with the Accountable Care Act (PPACA)." ELEO provides an easy to use, safe, single use alternative to the reusable solutions, eradicating any chance of cross infection. The average lifespan of reusable tourniquets is 2 years and numerous studies have found 75% could be contaminated with threatening organisms, such as MRSA, HIV, Hepatitis and now Ebola. Furthermore, "Given the encroaching threat of Ebola and other infectious diseases in North America, this simple clinician centered form of tourniquet safety, changes the game for providers and insurance companies. ELEO has the potential to impact shared saving plans in Accountable Care Organizations, whilst also positively impacting health insurance indicators such as HEDIS, with regards to Medicare Advantage Star Rating programs," as stated by Dr. Paul A. Markham President of V3 Healthcare Strategies.

Advertisement

Photo - http://photos.prnewswire.com/prnh/20141027/154471Photo - http://photos.prnewswire.com/prnh/20141027/154472

About V3 Healthcare Strategies

Advertisement

Based in Milwaukee, WI, V3 Healthcare Strategies is committed to bringing unique Accountable Care centered devices, software and services to market. The patented Hypo-tec system is yet another Next Generation, Patient Safety solution, bringing forth superiority over conventional product's specification, quality and lower price.  

CONTACT INFORMATION:                                                                       Dr. Paul A. MarkhamV3 Healthcare StrategiesEmail  www.v3healthcarestrategies.com Call +1.414.687.0272

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/v3-healthcare-strategies-launches-eleo-patented-single-use-safety-tourniquet-to-the-north-american-marketplace-131182283.html

SOURCE V3 Healthcare Strategies